Profile data is unavailable for this security.
About the company
2cureX AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of diagnostic substances to select treatment for cancer patients. The Company's product candidate, IndiTreat - CRC, aims at optimizing medical treatment for the colorectal cancer patients. Through IndiTreat - CRC, healthcare professionals collect a tumor sample from patients to create a number of three-dimensional micro tumors in order to test available chemotherapies and experimental treatments. The Company's product pipeline includes also IndiTreat - OVA, targeting ovarian cancer treatment, and IndiTreat - KDN, focusing on kidney cancer treatment. It operates through 2cureX A/S.
- Revenue in SEK (TTM)155.00k
- Net income in SEK-30.82m
- Incorporated2017
- Employees--
- Location2cureX ABc/o Mazars SET Revisionsbyra AB, Box 159LANDSKRONA 261 22SwedenSWE
- Websitehttps://www.2curex.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carbiotix AB (publ) | 1.70m | -14.55m | 8.85m | 10.00 | -- | 0.2949 | -- | 5.20 | -0.2357 | -0.2357 | 0.0196 | 0.1492 | 0.0658 | -- | 3.43 | 170,052.00 | -56.32 | -49.38 | -62.10 | -55.50 | 201.79 | 574.69 | -855.62 | -1,828.86 | -- | -45.74 | 0.00 | -- | 259.56 | -12.04 | -10.02 | -- | 13.64 | -- |
Diagonal Bio AB | 23.00k | -10.97m | 11.06m | 4.00 | -- | 0.0997 | -- | 480.76 | -0.1772 | -0.1772 | 0.0004 | 0.2768 | 0.0008 | -- | 2.00 | 4,600.00 | -36.58 | -- | -47.91 | -- | -35,765.22 | -- | -47,713.04 | -- | 0.2476 | -27.65 | 0.00 | -- | -88.67 | -- | 27.75 | -- | -- | -- |
2cureX AB | 155.00k | -30.82m | 13.99m | -- | -- | 1.02 | -- | 90.29 | -1.75 | -1.75 | 0.0088 | 0.7777 | 0.0048 | -- | 0.0838 | -- | -95.89 | -38.21 | -108.66 | -43.48 | -6,889.68 | -22,153.06 | -19,883.23 | -38,685.30 | -- | -46.08 | -- | -- | 72.22 | -- | -3.52 | -- | -- | -- |
Asarina Pharma AB (publ) | 0.00 | -12.83m | 14.26m | 2.00 | -- | 8.65 | -- | -- | -0.5666 | -0.5666 | 0.00 | 0.0728 | 0.00 | -- | -- | 0.00 | -111.87 | -61.25 | -157.85 | -71.89 | -- | -- | -- | -- | -- | -- | 0.3775 | -- | -- | -- | 3.43 | -- | -- | -- |
Stayble Therapeutics AB | 0.00 | -23.63m | 14.34m | 2.00 | -- | 0.8082 | -- | -- | -0.7935 | -0.7935 | 0.00 | 0.4059 | 0.00 | -- | -- | 0.00 | -153.00 | -78.64 | -183.58 | -95.58 | -- | -- | -- | -- | -- | -- | 0.0619 | -- | -- | -- | 3.22 | -- | -- | -- |
Amniotics AB (publ) | 0.00 | -30.87m | 15.03m | 9.00 | -- | 0.9594 | -- | -- | -0.0374 | -0.0374 | 0.00 | 0.0057 | 0.00 | -- | -- | 0.00 | -112.25 | -101.09 | -362.62 | -149.91 | -- | -- | -- | -- | 1.12 | -16.17 | 0.00 | -- | -- | -- | 35.75 | -- | -- | -- |
Lidds AB | 0.00 | -30.58m | 18.97m | 2.00 | -- | 1.86 | -- | -- | -0.5546 | -0.5546 | 0.00 | 0.0746 | 0.00 | -- | -- | 0.00 | -95.41 | -46.33 | -110.09 | -51.61 | -- | -1,934.24 | -- | -3,076.68 | -- | -- | 0.0812 | -- | -100.00 | -- | -9.08 | -- | -- | -- |
ATTANA AB | 5.52m | -11.54m | 28.71m | 10.00 | -- | 1.66 | -- | 5.20 | -0.0367 | -0.0367 | 0.0168 | 0.0447 | 0.1945 | -0.4851 | 2.16 | 552,453.00 | -40.62 | -37.18 | -52.55 | -46.66 | 129.03 | 175.97 | -208.89 | -254.69 | 0.3496 | -5.53 | 0.1539 | -- | -32.89 | 6.61 | 5.80 | -- | 8.21 | -- |
Gabather AB | 0.00 | -10.59m | 29.18m | -- | -- | -- | -- | -- | -0.6814 | -0.6814 | 0.00 | -0.1489 | 0.00 | -- | -- | -- | -144.39 | -56.57 | -1,110.23 | -67.36 | -- | -- | -- | -17,298,800.00 | -- | -- | -- | -- | -- | -- | -10.40 | -- | -- | -- |
Fluicell AB | 1.86m | -29.02m | 40.33m | 12.00 | -- | 1.60 | -- | 21.65 | -0.1936 | -0.1936 | 0.0109 | 0.0527 | 0.0796 | 0.5404 | 1.74 | 109,588.20 | -123.93 | -87.55 | -164.04 | -126.02 | 20.93 | 72.97 | -1,557.49 | -650.23 | 3.02 | -- | 0.00 | -- | 2.68 | 22.18 | -22.90 | -- | -- | -- |
SoftOx Solutions AS | 4.25m | -75.88m | 42.86m | 7.00 | -- | -- | -- | 10.08 | -1.71 | -1.71 | 0.0152 | -0.0179 | 0.0442 | -- | 1.16 | 612,427.10 | -78.78 | -50.11 | -146.86 | -63.61 | -- | -- | -1,784.14 | -639.34 | 0.0615 | -6.83 | 1.92 | -- | -1.88 | 10.06 | 44.55 | -- | 39.43 | -- |
Double Bond Phrmcutcl Intrntnl AB (publ) | 1.49m | -16.07m | 44.78m | 10.00 | -- | 6.61 | -- | 30.04 | -0.1635 | -0.1635 | 0.0145 | 0.0638 | 0.1306 | -- | 26.83 | 149,078.00 | -140.73 | -80.90 | -200.07 | -106.45 | -389.14 | -1,073.66 | -1,078.00 | -1,360.03 | -- | -2.71 | 0.00 | -- | 10.25 | 135.07 | -14.36 | -- | -- | -- |
Modus Therapeutics Holding AB | 0.00 | -14.96m | 45.82m | 2.00 | -- | 3.14 | -- | -- | -0.7495 | -0.7495 | 0.00 | 0.4056 | 0.00 | -- | -- | 0.00 | -128.10 | -141.06 | -502.76 | -278.44 | -- | -- | -- | -- | -- | -11.79 | 0.00 | -- | -- | -- | 2.31 | -- | -- | -- |